Baidu
map

Chest:阿片类药物和某些非阿片类药物可有效治疗成人慢性咳嗽

2013-10-11 sd3212 dxy

了解不同疗法对不明原因咳嗽、或顽固性咳嗽的相对效果,有助于加深人们对这一独特群体中各疗法的效果及其潜在不良反应的认识。为此,来自美国北卡罗莱那州杜克大学医学中心医学部的William博士等人进行了一项研究,研究结果在线发表于2013年8月8日的CHEST杂志上。研究发现,阿片类药物和某些非阿片类/非麻醉性止咳药对成人慢性咳嗽的治疗有明确效果。【原文下载】 该研究是一项文献荟萃分析性研究。研究者对

了解不同疗法对不明原因咳嗽、或顽固性咳嗽的相对效果,有助于加深人们对这一独特群体中各疗法的效果及其潜在不良反应的认识。为此,来自美国北卡罗莱那州杜克大学医学中心医学部的William博士等人进行了一项研究,研究结果在线发表于2013年8月8日的CHEST杂志上。研究发现,阿片类药物和某些非阿片类/非麻醉性止咳药对成人慢性咳嗽的治疗有明确效果。【原文下载

该研究是一项文献荟萃分析性研究。研究者对2012年6月前发表的相关英文研究报告进行了检索,并将其中有关比较慢性咳嗽对症治疗效果的文献纳入了分析研究之中。两名研究者筛查了纳入分析的每一篇文献摘要和全文,并对文献进行了数据提取、和质量评估。研究者使用元数据分析和随机效应模型对各种治疗方法的效果进行了归纳分析。

该研究的主要结果为:研究者最终将49篇文献纳入了分析,这些文献共涉及3067例患者、以及 68种治疗方法的疗效比较。在涉及到的研究药物中,阿片类药物、和一些非阿片/非麻醉性止咳药对成人慢性咳嗽的治疗有明确效果。与安慰剂相比,阿片类药物对咳嗽严重程度(以标准差,SMD表示)、及咳嗽频率(以率比,RR表示)的效应大小(effect sizes)分别为0.55、和 0.57 ;而右美沙芬的该效应量则分别为0.37、和0.40。但由于纳入分析的研究不够严谨、研究结果缺乏一致性、以及研究进行直接比较的病例数不多等原因,该荟萃研究的总体证据强度受到了限制。此外,研究者还发现,目前有关非药物治疗、及儿童咳嗽治疗方面的研究非常少见。

该研究结果显示:阿片类药物、和某些非阿片/非麻醉性止咳药对成人慢性咳嗽有明确的治疗效果。但由于荟萃分析所使用的证据有一定局限性,因此,还需要对不明原因性咳嗽、或顽固性咳嗽进行更深入的研究;同时,也需要有设计更严瑾、并且以病人的治疗效果为中心进行评估的研究报告,来对上述研究结论加以验证。

原文检索

Yancy WS, McCrory DC, Coeytaux RR, Schmit KM, Kemper AR, Goode A, Hasselblad V, Heidenfelder BL, Sanders GD.Efficacy and tolerability of treatments for chronic cough: a systematic review and meta-analysis.Chest. 2013 Aug 8【原文下载

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1929189, encodeId=514c192918912, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Mon Mar 10 11:09:00 CST 2014, time=2014-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2050372, encodeId=0be620503e23c, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Tue Mar 11 09:09:00 CST 2014, time=2014-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1710466, encodeId=69981e1046681, content=<a href='/topic/show?id=0ac299e481e' target=_blank style='color:#2F92EE;'>#非阿片类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99748, encryptionId=0ac299e481e, topicName=非阿片类)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Sat Jun 21 16:09:00 CST 2014, time=2014-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252981, encodeId=1c5612529813f, content=<a href='/topic/show?id=13159e8871d' target=_blank style='color:#2F92EE;'>#阿片类药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97887, encryptionId=13159e8871d, topicName=阿片类药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c83329, createdName=10518093zz, createdTime=Sun Oct 13 06:09:00 CST 2013, time=2013-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308991, encodeId=87fd1308991d2, content=<a href='/topic/show?id=a0179e879ac' target=_blank style='color:#2F92EE;'>#阿片类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97879, encryptionId=a0179e879ac, topicName=阿片类)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e12358, createdName=lhlxtx, createdTime=Sun Oct 13 06:09:00 CST 2013, time=2013-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619367, encodeId=0349161936e3c, content=<a href='/topic/show?id=8dd46061824' target=_blank style='color:#2F92EE;'>#有效治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60618, encryptionId=8dd46061824, topicName=有效治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sun Oct 13 06:09:00 CST 2013, time=2013-10-13, status=1, ipAttribution=)]
    2014-03-10 Smile2680
  2. [GetPortalCommentsPageByObjectIdResponse(id=1929189, encodeId=514c192918912, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Mon Mar 10 11:09:00 CST 2014, time=2014-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2050372, encodeId=0be620503e23c, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Tue Mar 11 09:09:00 CST 2014, time=2014-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1710466, encodeId=69981e1046681, content=<a href='/topic/show?id=0ac299e481e' target=_blank style='color:#2F92EE;'>#非阿片类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99748, encryptionId=0ac299e481e, topicName=非阿片类)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Sat Jun 21 16:09:00 CST 2014, time=2014-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252981, encodeId=1c5612529813f, content=<a href='/topic/show?id=13159e8871d' target=_blank style='color:#2F92EE;'>#阿片类药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97887, encryptionId=13159e8871d, topicName=阿片类药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c83329, createdName=10518093zz, createdTime=Sun Oct 13 06:09:00 CST 2013, time=2013-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308991, encodeId=87fd1308991d2, content=<a href='/topic/show?id=a0179e879ac' target=_blank style='color:#2F92EE;'>#阿片类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97879, encryptionId=a0179e879ac, topicName=阿片类)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e12358, createdName=lhlxtx, createdTime=Sun Oct 13 06:09:00 CST 2013, time=2013-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619367, encodeId=0349161936e3c, content=<a href='/topic/show?id=8dd46061824' target=_blank style='color:#2F92EE;'>#有效治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60618, encryptionId=8dd46061824, topicName=有效治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sun Oct 13 06:09:00 CST 2013, time=2013-10-13, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1929189, encodeId=514c192918912, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Mon Mar 10 11:09:00 CST 2014, time=2014-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2050372, encodeId=0be620503e23c, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Tue Mar 11 09:09:00 CST 2014, time=2014-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1710466, encodeId=69981e1046681, content=<a href='/topic/show?id=0ac299e481e' target=_blank style='color:#2F92EE;'>#非阿片类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99748, encryptionId=0ac299e481e, topicName=非阿片类)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Sat Jun 21 16:09:00 CST 2014, time=2014-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252981, encodeId=1c5612529813f, content=<a href='/topic/show?id=13159e8871d' target=_blank style='color:#2F92EE;'>#阿片类药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97887, encryptionId=13159e8871d, topicName=阿片类药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c83329, createdName=10518093zz, createdTime=Sun Oct 13 06:09:00 CST 2013, time=2013-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308991, encodeId=87fd1308991d2, content=<a href='/topic/show?id=a0179e879ac' target=_blank style='color:#2F92EE;'>#阿片类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97879, encryptionId=a0179e879ac, topicName=阿片类)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e12358, createdName=lhlxtx, createdTime=Sun Oct 13 06:09:00 CST 2013, time=2013-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619367, encodeId=0349161936e3c, content=<a href='/topic/show?id=8dd46061824' target=_blank style='color:#2F92EE;'>#有效治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60618, encryptionId=8dd46061824, topicName=有效治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sun Oct 13 06:09:00 CST 2013, time=2013-10-13, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1929189, encodeId=514c192918912, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Mon Mar 10 11:09:00 CST 2014, time=2014-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2050372, encodeId=0be620503e23c, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Tue Mar 11 09:09:00 CST 2014, time=2014-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1710466, encodeId=69981e1046681, content=<a href='/topic/show?id=0ac299e481e' target=_blank style='color:#2F92EE;'>#非阿片类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99748, encryptionId=0ac299e481e, topicName=非阿片类)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Sat Jun 21 16:09:00 CST 2014, time=2014-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252981, encodeId=1c5612529813f, content=<a href='/topic/show?id=13159e8871d' target=_blank style='color:#2F92EE;'>#阿片类药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97887, encryptionId=13159e8871d, topicName=阿片类药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c83329, createdName=10518093zz, createdTime=Sun Oct 13 06:09:00 CST 2013, time=2013-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308991, encodeId=87fd1308991d2, content=<a href='/topic/show?id=a0179e879ac' target=_blank style='color:#2F92EE;'>#阿片类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97879, encryptionId=a0179e879ac, topicName=阿片类)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e12358, createdName=lhlxtx, createdTime=Sun Oct 13 06:09:00 CST 2013, time=2013-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619367, encodeId=0349161936e3c, content=<a href='/topic/show?id=8dd46061824' target=_blank style='color:#2F92EE;'>#有效治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60618, encryptionId=8dd46061824, topicName=有效治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sun Oct 13 06:09:00 CST 2013, time=2013-10-13, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1929189, encodeId=514c192918912, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Mon Mar 10 11:09:00 CST 2014, time=2014-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2050372, encodeId=0be620503e23c, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Tue Mar 11 09:09:00 CST 2014, time=2014-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1710466, encodeId=69981e1046681, content=<a href='/topic/show?id=0ac299e481e' target=_blank style='color:#2F92EE;'>#非阿片类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99748, encryptionId=0ac299e481e, topicName=非阿片类)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Sat Jun 21 16:09:00 CST 2014, time=2014-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252981, encodeId=1c5612529813f, content=<a href='/topic/show?id=13159e8871d' target=_blank style='color:#2F92EE;'>#阿片类药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97887, encryptionId=13159e8871d, topicName=阿片类药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c83329, createdName=10518093zz, createdTime=Sun Oct 13 06:09:00 CST 2013, time=2013-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308991, encodeId=87fd1308991d2, content=<a href='/topic/show?id=a0179e879ac' target=_blank style='color:#2F92EE;'>#阿片类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97879, encryptionId=a0179e879ac, topicName=阿片类)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e12358, createdName=lhlxtx, createdTime=Sun Oct 13 06:09:00 CST 2013, time=2013-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619367, encodeId=0349161936e3c, content=<a href='/topic/show?id=8dd46061824' target=_blank style='color:#2F92EE;'>#有效治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60618, encryptionId=8dd46061824, topicName=有效治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sun Oct 13 06:09:00 CST 2013, time=2013-10-13, status=1, ipAttribution=)]
    2013-10-13 lhlxtx
  6. [GetPortalCommentsPageByObjectIdResponse(id=1929189, encodeId=514c192918912, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Mon Mar 10 11:09:00 CST 2014, time=2014-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2050372, encodeId=0be620503e23c, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Tue Mar 11 09:09:00 CST 2014, time=2014-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1710466, encodeId=69981e1046681, content=<a href='/topic/show?id=0ac299e481e' target=_blank style='color:#2F92EE;'>#非阿片类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99748, encryptionId=0ac299e481e, topicName=非阿片类)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Sat Jun 21 16:09:00 CST 2014, time=2014-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252981, encodeId=1c5612529813f, content=<a href='/topic/show?id=13159e8871d' target=_blank style='color:#2F92EE;'>#阿片类药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97887, encryptionId=13159e8871d, topicName=阿片类药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c83329, createdName=10518093zz, createdTime=Sun Oct 13 06:09:00 CST 2013, time=2013-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308991, encodeId=87fd1308991d2, content=<a href='/topic/show?id=a0179e879ac' target=_blank style='color:#2F92EE;'>#阿片类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97879, encryptionId=a0179e879ac, topicName=阿片类)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e12358, createdName=lhlxtx, createdTime=Sun Oct 13 06:09:00 CST 2013, time=2013-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619367, encodeId=0349161936e3c, content=<a href='/topic/show?id=8dd46061824' target=_blank style='color:#2F92EE;'>#有效治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60618, encryptionId=8dd46061824, topicName=有效治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Sun Oct 13 06:09:00 CST 2013, time=2013-10-13, status=1, ipAttribution=)]

相关资讯

WHO:扩大低、中等收入环境下的阿片类药物依赖治疗

  《世界卫生组织简报》2013;91:82-82A.doi: 10.2471/BLT.12.110783   从使用者数量看,阿片类药物(即鸦片、海洛因和处方止痛药)是世界上第三大类药物。阿片类药物依赖的全球流行率大约在0.6%到0.8%之间,阿片类药物消费和依赖治疗的需求在欧洲和亚洲最高。阿片类药物使用者死于药物过量的风险特别高。由于不安全的注射行为,注射阿片类药物的人还面临感染爱

Baidu
map
Baidu
map
Baidu
map